baber/WOPTO huggingface dataset:
Patent PT-1277750-E (PT)
Inventor: HONDA TAKESHI
IPC: A61P31/12
Filed: 2001-04-25
Abstract: Hydrates of the compound of formula (I) and crystalline forms thereof have excellent storage stability and are useful medicaments. <CHEM>
Patent PT-1283804-E (PT)
Inventor: RAMSEY CHRISTOPHER PAUL
IPC: B65D51/24
Filed: 2001-05-23
Abstract: A sequentially moulded closure arrangement (1) comprising a body (4), which forms the shoulder of a container, such as a tube (2), and defines a dispensing passageway, a cover (5), to seal the dispensing passageway, and a fixing ring (7) to join the body to the container. The cover is connected to the body or the fixing ring by a moulded hinge (6) and the cover and fixing ring are sequentially moulded together as an integral moulding, removing the requirement to assemble the cover, body and fixing ring in a separate assembly operation. The arrangement has further advantages relating to cleanliness and ease of dispensing.
Patent PT-1328285-E (PT)
Inventor: SUNE WIKNER
IPC: A61K8/97
Filed: 2001-09-27
Abstract: An oral preparation for reduction of mammalian, e.g. human, cat or dog, plaque and/or calculus, such as bacterial plaque, arteriosclerotic plaque, atherosclerotic plaque, pleural plaque, dental calculus, renal calculus, biliary calculus, and prostatic calculus, contains a Ascophyllum sp., especially A. nodosum, seaweed or an extract thereof. The oral preperation is suitable for use in prophylactic and/or therapeutic method of treating plaque and/or calculus in a mammalian individual.
Patent PT-1261074-E (PT)
Inventor: BALS JOHANNES
IPC: H01R13/58
Filed: 2002-04-12
Abstract: The electrical cable (2) passes through a housing part (1) that is cylindrical and has an end section having a ring of angled radial claws (14). The inner surface is coated with a sealing material (20). When an end cap (12) is threaded onto the housing the claws are forced radially inwards to grip the cable and also provide a seal.
Patent PT-1390025-E (PT)
Inventor: HORROBIN DAVID FREDERICK
IPC: A23L1/30
Filed: 2002-05-09
Abstract: The co-administration of ubiquinone (coenzyme Q) with eicosapentaenoic acid, which may be supplemented with or replaced by one or more of the unsaturated fatty acids gamma-linolenic acid, dihomogamma-linolenic acid, arachidonic acid and stearidonic acid. The fatty acids docosahexaenoic acid and linoleic acid should be present in less than 10%.
Patent PT-1385695-E (PT)
Title: Container for compacting paper waste
Inventor: ERIKSEN BENT
IPC: B65F1/14
Filed: 2002-04-19
Abstract: A compacting container compresses cellulose-containing waste, paper and cardboard. The container has a filling opening which can be closed by a door and pulling hydraulic cylinders. The door pivots about a horizontal axis at the bottom of the container. A compressor mounted at the filling end, extends across an interior of the container and is suspended by one side edge on a shaft traversing the container at a beam. The waste is filled into the door and its side edges. When the door is full the compressor is activated as respective cylinders pivot the transverse compressor down against the paper waste. Shovelling occurs into the container while the door is simultaneously drawn against the container open end. Waste is compressed into container the interior. A greater container volume is used, and the pressing force is further reduced for simple location of the pulling cylinders along the container sides.
Patent PT-1444903-E (PT)
Title: Method for producing ultrafine dispersion water of noble metal ultrafine particles
Inventor: YOSHIHIRO HIRATA
IPC: A61K35/02
Filed: 2002-10-11
Abstract: Efficiently produce micro-dispersion water of super-fine noble metal particles having a desired concentration by using a very safe, compact production apparatus comprising a power supply for high-voltage/current discharge, a high-voltage discharge generator equipped with a noble metal electrode and its counter electrode, a water tank, a water inlet to the water tank, and an outlet for micro-dispersion water of super-fine noble metal particles, by causing plasma discharge in water between the noble metal electrode and its counter electrode and then causing the generated noble metal ion vapor to contact, and micro-disperse in, water. The obtained water can be effectively used as drinking water.
Patent PT-1975158-E (PT)
Title: Novel pyrrole derivatives with histone deacetylase inhibitor activity
Inventor: MORA FERNANDO PEDRO COSSIO
IPC: A61K31/40
Filed: 2005-12-27
Abstract: The invention describes new compounds derived from formula I pyrroles, methods for obtaining them and their application as drugs in pharmaceutical compositions for the treatment of cancer due to their inhibitory activity on certain histone deacetylases.
Patent PT-1833473-E (PT)
Title: 5ht2c receptor modulator compositions and methods of use
Inventor: BEHAN DOMINIC P
IPC: A61P3/04
Filed: 2005-12-21
Abstract: The present invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist. In addition, the invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist having Formula (I): or a pharmaceutically acceptable salt, solvate or hydrate thereof. The compositions are useful in pharmaceutical compositions whose use includes the treatment of obesity.
Patent PT-1930258-E (PT)
Title: Conveying roller
Inventor: ARNOLD OLAF
IPC: B65G39/07
Filed: 2007-12-07
Abstract: Conveying roller (1) comprises an outer surface (7) made from an electrically conducting plastic which is in electrical contact with the roller base (3). Preferred Features: The roller has a casing (2) with an inner roller body (11) with is covered with an electrically conducting layer (12) made from an electrically conducting plastic. The thickness of the electrically conducting layer is less than the wall thickness of the inner roller body.
Patent PT-1970460-E (PT)
Title: Cast iron for manufacturing parts for friction braking devices and method for producing the cast iron
Inventor: KOECHER UDO
IPC: C22C37/00
Filed: 2007-03-07
Abstract: Cast iron comprises a base iron composition containing (in wt.%) 2.6-2.9 carbon, 1.2-2.0 silicon, 2.0-2.5 phosphorus, less than 0.5 manganese and less than 0.2 sulfur. Steadite is added to the base iron composition. An independent claim is also included for a method for producing a cast iron.
Patent PT-2139750-E (PT)
Title: Lock for keeping a two-wheeled vehicle in a parked condition
Inventor: LAQUIEZE ALAIN
IPC: B62H3/04
Filed: 2008-04-21
Abstract: This invention relates to a lock for keeping a two-wheeled vehicle in a parked condition. The lock includes a fixed bracket having a movable device able to move from an open retracted position to a position in which it locks at least one of the wheels, and vice versa. The movable device locks the wheel by gripping the ends of its axle through pads made of an elastic material.
Patent PT-2240454-E (PT)
Title: Mesoionic pesticides
Inventor: MCCANN STEPHEN FREDERICK
IPC: A01N43/54
Filed: 2009-01-30
Abstract: Disclosed are compounds of Formula 1,   
wherein 
X is O; 
Y is O; 
and R 1 , R 2 , R 3  and R 4  are as defined in the disclosure.  Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.
Patent PT-653639-E (PT)
Inventor: JANE STEPHANIE SENIOR
IPC: B01L3/00
Filed: 1993-11-12
Abstract: An analytical device for determining the presence and/or concentration of an analyte in a sample liquid comprises a hollow casing; means such as an assay strip within said casing for selectively capturing an analyte in sample liquid applied to the device; a bibulous sample liquid receiving member at or adjacent to a first extremity of said casing which collects sample liquid and transports it into the casing; a window in the casing at a location remote from the first extremity of the casing; and a single cap which can be applied in turn over the window during sample collection, and then over the sample receiving member. <IMAGE>
Patent PT-811384-E (PT)
Title: Muscle protein decomposition inhibitor containing il-6 receptor antibody
Inventor: TSUJINAKA TOSHIMASA
IPC: A61P21/00
Filed: 1996-02-13
Abstract: The present invention provides a muscle protein proteolysis inhibiting agent comprising antibody to Interleukin-6 receptor (IL-6R antibody). Antibodies of animals other than humans such as mice and rats, chimeric antibodies of these antibodies with human antibodies, and reshaped human antibodies and so forth can be used for the IL-6R antibody. The muscle protein proteolysis inhibiting agent of the present invention is useful in the inhibition of muscle protein proteolysis observed in diseases such as cancerous cachexia, sepsis, serious trauma or muscular dystrophy.
Patent PT-1019428-E (PT)
Inventor: AGRAWAL SUDHIR
IPC: A61K31/7088
Filed: 1996-08-16
Abstract: The invention relates to modified oligonucleotides that are useful for studies of gene expression and for the antisense therapeutic approach. The invention provides inverted hybrid oligonucleotides and inverted chimeric oligonucleotides, both of which produce reduced side effects, relative to traditional phosphorothioate, hybrid or chimeric oligonucleotides.
Patent PT-838680-E (PT)
Inventor: ALLARD WILLIAM JEFFREY
IPC: G01N33/536
Filed: 1997-10-13
Abstract: A method for determining the complexed forms of immunologically determinable prostate specific antigen (cPSA) in a blood sample, e.g., by two-site immunometric assays, in which the blood sample is treated to render free PSA (fPSA) immunologically nondetectable. A particularly preferred immunometric assay method employs three anti-PSA antibodies: an antibody that binds to both cPSA and fPSA (anti-tPSA), a second anti-tPSA antibody which is characterized by the unique property that binding to fPSA is blocked by binding of fPSA-specific antibodies, and a third antibody which is a fPSA-specific antibody. Thus, binding of the fPSA-specific antibody to PSA in the sample allows only cPSA to be measured in the immunometric assay. Measurement of cPSA blood levels has been found to provide a method for aiding in the diagnosis and monitoring of prostate cancer that is highly sensitive and specific, and eliminates the need for a significant number of patients to undergo unnecessary prostate biopsy.
Patent PT-907605-E (PT)
Inventor: LANGER HEINZ
IPC: B66F9/14
Filed: 1997-06-06
Abstract: A telescoping table with a base and at least two slides and a support table, which can be displaced linearly on it in a telescoping manner, and with drive devices assigned to these components, is to be operated in such a way that, even at small degrees of extension, at least the support table is fully or almost fully extended on the slide which guides it, and, to the extent possible, the second slide is also extended relatively far forward on the first slide, the required drive devices being installed in readily accessible and easy-to-maintain locations. For this purpose, it is proposed that the base be equipped with two drive devices, the first of which is connected only to the first slide, whereas the second operates tension cables, tension belts, tension bands, tension chains, and/or lengths of chain which operate a second slide or a second slide plus additional slides as well as the support table.
Patent PT-855209-E (PT)
Title: Psa process for purifying hydrogen
Inventor: PLEE DOMINIQUE
IPC: B01D53/04
Filed: 1998-01-16
Abstract: PSA for obtaining pure hydrogen from gaseous mixtures containing (other than hydrogen) carbon monoxide and/or nitrogen comprises use of a faujasite adsorbent with a silicon/aluminium ratio of 1-3, in which at least 85% of the alumina tetrahedra in the crystal lattice are associated with lithium and carbon cations.The ratio of lithium to lithium + calcium is at least 70%.
Patent PT-1032414-E (PT)
Inventor: GUEZ DAVID
IPC: A61K31/404
Filed: 1998-03-03
Abstract: The present invention relates to the use of a combination of an antiotensin-converting enzyme inhibitor (CEI) and of a diuretic for the treatment of arteriolo-capillary microcirculatory disorders and to pharmaceutical compositions containing the same.
Patent PT-982990-E (PT)
Title: Stable liquid calcium ascorbate compositions and methods of manufacture and use
Inventor: HEGENAUER JOHN C
IPC: A23L33/15
Filed: 1999-02-05
Abstract: Liquid vitamin C concentrate compositions comprise a mineral ascorbate and a pharmacologically acceptable liquid organic polyol solvent for the mineral ascorbate, the concentrate having a pH between about 5 and 7. The concentrate may also contain an aldonic compound and/or a pharmacologically acceptable zinc compound. The concentrate compositions are prepared by heating the solvent to 50-90° C. and mixing the ascorbate and/or aldonic compound and/or zinc compound into the heated solvent, preferably in the absence of oxygen. These concentrate compositions are also characterized as a composition which comprises the reaction product of a mineral ascorbate and a pharmacologically acceptable liquid organic polyol solvent and, optionally an aldonic compound and/or a soluble non-toxic zinc compound, which reaction product includes 4-hydroxy-5-methyl-3(2H)-furanone and/or 3-hydroxy kojic acid.Finished vitamin C products, characterized by excellent long term vitamin C stability, are conveniently prepared by incorporating the concentrates into finished cosmetic, medical and food products.
Patent PT-1104320-E (PT)
Inventor: BRAIN ARCHIBALD IAN JEREMY
IPC: A61M16/04
Filed: 1999-08-11
Abstract: A laryngeal-mask airway device including provision for drainage of the esophagus including an inflatable main-cuff and a backplate having a laryngeal-side and a pharyngeal-side. The backplate also has an external tube joint adjacent to the proximal region of the main-cuff. The backplate is hermetically bonded to the periphery of the main-cuff establishing separation between a laryngeal-chamber region and a pharyngeal region. A distally open evacuation tube includes a distal portion which longitudinally traverses the interior of the distal region of the main-cuff in sealed relation therewith for operative engagement and communication with the inlet of the oesophagus. The evacuation tube traverses the laryngeal-chamber region generally adjacent to the laryngeal-side of the backplate and passages through a proximally located tube-joint to the pharyngeal region. An airway tube also extends into the tube joint for communication with an airway port to provide a flowpath between the airway tube and laryngeal-chamber region.
Patent SG-15593-G (SG)
Title: Phenoxyacetic acid compounds,their preparation,pharmaceutical composition and use
IPC: A61K31/18
Filed: 1993-02-11
Abstract: Novel phenoxyacetic acid of the formula: <CHEM> wherein Ring A is phenylene group or a phenylene group having 1 to 2 substituent(s) selected from a lower alkyl group, a lower alkoxy group and a halogen atom; either one or two group(s) of R<1>, R<2>, R<3> and R<4> are a lower alkyl group, and the other groups are hydrogen atom; R<5> is phenyl group or a phenyl group having 1 to 3 substituent(s) selected from a lower alkyl group, a halogen atom, a lower alkoxy group and nitro group; and -COOR<6> is carboxyl group or a protected carboxyl group, or a salt thereof, their preparation, a pharmaceutical composition containing them as active ingredient, and their use in the preparation of a medicament for the treatment or prophylaxis of thrombotic diseases or embolism are disclosed.
Patent SG-39792-G (SG)
Title: Nasal devices
IPC: A61M15/08
Filed: 1992-04-10
Abstract: Devices for improving nasal breathing and to nasal drug delivery devices having two end portions of a resilient material in the form of relatively thin tabs, preferably having a gentle curvature, interconnected by a resilient member. Upon bending of the connecting member, the two end tabs can be positioned in respective nostrils where they will be biased outwardly against the nasal side walls, the outward biasing force being sufficient to locate the device in the nose and to dilate the anterior part of each nasal cavity by an amount to improve nasal breathing. No part of the device is grippingly engaged with the septum and a substantial free passage for air flow remains between the septum wall and the nasal side wall-contacting face of each end tab.
Patent IE-900169-L (IE)
Title: Substituted quinolinecarboxylic acids
IPC: A61K31/47
Filed: 1990-01-16
Abstract: Substituted quinolinecarboxylic acids useful in the treatment of arthritis by inhibiting the progressive joint deterioration characteristic of arthritic disease and for inducing immunosuppression are disclosed. Methods of synthesis and use of the novel compounds are also disclosed.
Patent IE-36116-L (IE)
Title: N -(furylmethyl)morphinanes
IPC: C07D405/04
Filed: 1972-02-18
Abstract: 1379781 N-furylmethyl-morphinane compounds BOEHRINGER INGELHEIM GmbH 18 Feb 1972 [19 Feb 1971] 7650/72 Heading C2C] Novel compounds of the Formula I wherein R denotes hydrogen, methyl or acetyl and R 1 denotes hydrogen, methyl or ethyl, and acid addition salts, racemic mixtures of optically active isomers, may be obtained (a) by reducing a compound of the formula (wherein Z is COOH, CHO, CH 2 OH, CH 3 CO, or -CH 2 CHO), or (b) by catalytic hydrogenation of a compound of Formula IVa (wherein Z is a halogen atom), (c) by methylating or acetylating a compound of Formula I (wherein R denotes a hydrogen atom), (d) by dealkylating, dearylating or deacylating a compound of Formula IVa where Z is R 1 and R1 is an alkyl, aralkyl or acyl group, (e) by reacting a compound of the Formula (II) (where R1 denotes H, alkyl, aralkyl or acyl), with a compound of the Formula (III) (wherein Z is H, halogen, CH 3 , C 2 H 5 , CHO, COOH, CH 2 OH, CH 3 CO, or -CH 2 CHO and X represents a halogen atom or an alkyl- or aryl-sulphonyloxy group), (f) by reacting a compound of Formula II with formaldehyde and a compound of Formula V (g) by reacting a compound of Formula II with a compound of the Formula VI (h) by reducing a compound of Formula (VIII), and where necessary in any of the above methods reducing Z to R 1 , dealkylating or deacylating R1 and converting to CH 3 or CH 3 CO. When Z is COOH it can be converted to H by decarboxylation with copper and quinoline. Pharmaceutical compositions having analgesic, anti-tussive and morphine antagonistic effects comprise a compound of Formula I or physiologically compatible salt thereof in association with a pharmaceutical carrier or excipient, in forms suitable for oral, rectal, enteral or parenteral administration. (From GB1379781 A) [FR2125599A1]
Patent IE-37372-L (IE)
Title: Apparatus for treating malt nstruction.
IPC: B23K37/04
Filed: 1973-03-06
Abstract: For use in the course of forming a venturi-shaped flame-ignition throat in a venturi-shaped duct in a boiler, the jug being used for the positioning of studs for welding to circulation tubes so as to extend from the latter inwards in the direction of the duct axis, the tubes being disposed in banks at each of two diametrically opposed regions of the duct in non-contiguous relationship over the major parts of their lengths with their axes following the curvature of the duct in planes normal or substantially normal to said circulation axis, the jig comprising an internally-braced metal ring of diameter to fit with clearance within the smaller diameter end of either one of the truncated conical lengths of the duct, L-shaped support brackets secured to the external periphery of said ring at circumferentially spaced locations and providing first limbs parallel to the ring axis and outwardly projecting second limbs spaced from and parallel to radii of said ring, the first limbs being adjustable in length and the second limbs having therein elongate holes enabling positional adjustment relative thereto of locating studs welded to the circulation tubes closest to the larger diameter end of said either one truncated conical length of the duct to fix the jig in position, sections of a frusto-conical skirt also secured to the external periphery of the ring and mounting mandrel-guiding tubes whereof, in use, the axes are normal to the axes of other circulaton tubes at said two opposed regions and mandrels insertable through said tubes and having tapped ends into which are adapted to be screwed studs to be welded to said other circulation tubes.
[US3815891A]
Patent IE-33781-L (IE)
Title: Acidic zinc electrolytes
IPC: C25D3/22
Filed: 1970-04-09
Abstract: 1309946 Electro-depositing glossy zinc SCHERING AG 8 April 1970 [12 April 1969] 16668/70 Heading C7B Glossy zinc is electro-deposited from an acidic zinc electrolyte containing at least one poly-ethylene glycol and a ketone of formula R 1 CO R 2 each represents an aryl, a coumarinyl or 5- or 6- membered heterocyclic group containing N and/or S and/or O, alone or attached to a saturated or unsaturated bivalent hydrocarbon group (e.g. up to 4C), or represents a phenylcarbonylalkyl group, or in which R 1 represents one of the above and R 2 a saturated or unsaturated aliphatic hydrocarbon group (e.g. up to 4C), an alkoxycarbonylalkyl or a cyanoalkyl group. Many examples of ketones are specified in which R 1 , R 2 each represents a (substituted) phenyl, naphthyl, coumarinyl, pyridyl, furyl, thienyl or pyranyl group, which may be attached to a vinylene group, or a phenylcarbonylmethyl group. The polyethylene glycol can have 5-500 CH 2 CH 2 O units and a total concentration of 0À1- 20 g/l. The total concentration of the ketone is preferably 0À01-5 g/l. The electrolyte may also contain, besides zinc and ammonium chloride or sulphate, sodium chloride or sulphate, optionally boric acid and/or an aliphatic and/or aromatic carboxylic acid, e.g. acetic, benzoic or salicylic acid, other glossing agents e. g. aromatic aldehydes, and a wetting agent e.g. Na-n-octylsulphate. The electrolyte may be agitated by air injection or cathode movement.
[GB1309946A]
Patent IE-40736-L (IE)
Title: Separating solids from a gas stream
IPC: B04C5/10
Filed: 1975-03-05
Abstract: 1500117 Cyclone separators BAYER AG 6 March 1975 [6 March 1974] 9340/75 Heading B2P Solids are separated from a gas stream by passing the solids-laden gas stream through a cyclonic separation zone founded by the inner surface of an at least partly porous wall, causing a flushing gas to flow into the separation zone through the wall so that a film of flushing gas is formed over the inner surface of the wall, and withdrawing the solids and the gas stream independently from the separation zone. As shown in Fig. 2, the solids-laden gas stream is introduced through an inlet pipe 1 tangentially into a double-conical cyclone having inner porous walls 6 and outer gasimpervious walls 4 defining with the walls 6 intermediate zones 8 to which flushing gas is supplied via conduits 10. The gas stream outlet pipe is also provided with an inner porous wall 7 surrounded by a gas-impervious outer wall 5, the intermediate zone 9 being supplied with flushing gas through a conduit 10. In another embodiment, the cyclone is of the single-cone type. Water, e.g. in vapour form, may be added to the gas strain before or after it is introduced into the cyclone. The outer walls of the cyclone may be cooled with water. The inner walls 6, 7 may be made of metallic or non-metallic materials, e.g. ceramics, carbon or graphite; the porosity may be produced by sintering, punching, drilling or electrolytically; or the walls may be made from screens or cloths. The flushing gas may consist of one, e.g. nitrogen, chlorine or carbon dioxide, which is inert to the solidsladen gas stream, to the solids and to the constructional materials of the cyclone. Alternatively, part of the separated gas which has been cooled may be recycled as flushing gas. Examples of solids which may be separated out of gases are given.
[GB1500117A]